41 related articles for article (PubMed ID: 9382974)
1. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival.
Guglielmi A; Ruzzenente A; Sandri M; Pachera S; Pedrazzani C; Tasselli S; Iacono C
J Gastrointest Surg; 2007 Feb; 11(2):143-9. PubMed ID: 17390163
[TBL] [Abstract][Full Text] [Related]
2. Parameters Predicting Microvascular Invasion and Poor Differentiation in Hepatocellular Carcinoma Patients with Normal Alpha-fetoprotein Level Before Liver Transplantation.
Kılcı BM; İnce V; Carr BI; Usta S; Bağ HG; Şamdancı E; Işık B; Yılmaz S
Turk J Gastroenterol; 2023 Jul; 34(7):753-759. PubMed ID: 37326153
[TBL] [Abstract][Full Text] [Related]
3. Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma.
Ganne-Carrié N; Nault JC; Ziol M; N'Kontchou G; Nahon P; Grando V; Bourcier V; Barge S; Beaugrand M; Trinchet JC; Seror O
Hepat Oncol; 2014 Oct; 1(4):395-408. PubMed ID: 30190975
[TBL] [Abstract][Full Text] [Related]
4. Risk factors, patterns, and outcome predictors of late recurrence in patients with hepatocellular carcinoma after curative resection: A large cohort study with long-term follow-up results.
Hsiao CY; Ho CM; Ho MC; Cheng HY; Wu YM; Lee PH; Hu RH
Surgery; 2024 Mar; ():. PubMed ID: 38519406
[TBL] [Abstract][Full Text] [Related]
5. Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
Sobotka LA; Hake T; Kelly C; Mousa L
Clin Case Rep; 2019 Feb; 7(2):251-253. PubMed ID: 30847183
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Serum Albumin Level and Albumin-Based Mono- and Combination Biomarkers in Patients with Hepatocellular Carcinoma.
Jeng LB; Chan WL; Teng CF
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831351
[TBL] [Abstract][Full Text] [Related]
7. Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization.
Choi SJ; Kim J; Seo J; Kim HS; Lee JM; Park H
Eur Radiol; 2016 Jan; 26(1):225-34. PubMed ID: 25991485
[TBL] [Abstract][Full Text] [Related]
8. Predisposing factors of hepatocellular carcinoma recurrence following complete remission in response to transarterial chemoembolization.
Jin YJ; Chung YH; Kim JA; Park W; Lee D; Shim JH; Lee D; Kim KM; Lim YS; Lee HC; Lee YS; Kim PN; Sung KB
Dig Dis Sci; 2013 Jun; 58(6):1758-65. PubMed ID: 23361574
[TBL] [Abstract][Full Text] [Related]
9. Addition of transcatheter arterial chemoembolization decreased local recurrence but had no survival benefit to percutaneous ethanol injection therapy for patients with small hepatocellular carcinoma: A multicenter randomized control study.
Mizuki A; Tatemichi M; Tsukada N; Nagamatsu R; Kawaguchi M; Itoshima T; Maruyama S; Satou A; Imari Y; Kawatoko T; Shimono J; Nagata H;
Oncol Lett; 2010 Sep; 1(5):855-859. PubMed ID: 22966394
[TBL] [Abstract][Full Text] [Related]
10. Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines.
Abdo AA; Hassanain M; AlJumah A; Al Olayan A; Sanai FM; Alsuhaibani HA; Abdulkareem H; Abdallah K; AlMuaikeel M; Al Saghier M; Babatin M; Kabbani M; Bazarbashi S; Metrakos P; Bruix J; ;
Ann Saudi Med; 2012; 32(2):174-99. PubMed ID: 22366832
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
Shiina S; Tateishi R; Arano T; Uchino K; Enooku K; Nakagawa H; Asaoka Y; Sato T; Masuzaki R; Kondo Y; Goto T; Yoshida H; Omata M; Koike K
Am J Gastroenterol; 2012 Apr; 107(4):569-77; quiz 578. PubMed ID: 22158026
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors.
Kim SU; Kim DY; Park JY; Ahn SH; Nah HJ; Chon CY; Han KH
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1377-84. PubMed ID: 18483745
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies for hepatocellular carcinoma in cirrhosis.
Helton WS; Di Bisceglie A; Chari R; Schwartz M; Bruix J
J Gastrointest Surg; 2003; 7(3):401-11. PubMed ID: 12654567
[No Abstract] [Full Text] [Related]
14. Preoperative predictors of survival after resection of small hepatocellular carcinomas.
Wayne JD; Lauwers GY; Ikai I; Doherty DA; Belghiti J; Yamaoka Y; Regimbeau JM; Nagorney DM; Do KA; Ellis LM; Curley SA; Pollock RE; Vauthey JN
Ann Surg; 2002 May; 235(5):722-30; discussion 730-1. PubMed ID: 11981219
[TBL] [Abstract][Full Text] [Related]
15. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
Poon RT; Fan ST; Tsang FH; Wong J
Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.
Llovet JM; Mas X; Aponte JJ; Fuster J; Navasa M; Christensen E; Rodés J; Bruix J
Gut; 2002 Jan; 50(1):123-8. PubMed ID: 11772979
[TBL] [Abstract][Full Text] [Related]
17. Localized Hepatocellular Carcinoma.
Jeyarajah DR
Curr Treat Options Gastroenterol; 2000 Dec; 3(6):463-472. PubMed ID: 11096607
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
Castellano L; Calandra M; Del Vecchio Blanco C; de Sio I
J Hepatol; 1997 Nov; 27(5):862-70. PubMed ID: 9382974
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
Koda M; Murawaki Y; Mitsuda A; Ohyama K; Horie Y; Suou T; Kawasaki H; Ikawa S
Cancer; 2000 Feb; 88(3):529-37. PubMed ID: 10649243
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
